Published in J Clin Psychiatry on February 01, 2002
Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (2010) 1.62
Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci (2005) 1.49
Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (2011) 1.41
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol (2012) 1.19
Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment. Adv Med (2014) 0.97
Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol (2013) 0.97
Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study. Schizophr Bull (2014) 0.94
Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study. Eur Arch Psychiatry Clin Neurosci (2010) 0.87
Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry (2011) 0.86
Comparative Analysis of Cognitive Function in Schizophrenia with and without Obsessive Compulsive Disorder. Psychiatry Investig (2009) 0.82
Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis: Systematic review of evidence. World J Psychiatry (2016) 0.79
Interventions for obsessive compulsive symptoms in people with schizophrenia. Cochrane Database Syst Rev (2005) 0.78
Evidence for a Shared Etiological Mechanism of Psychotic Symptoms and Obsessive-Compulsive Symptoms in Patients with Psychotic Disorders and Their Siblings. PLoS One (2015) 0.75
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
The environment and schizophrenia: the role of cannabis use. Schizophr Bull (2005) 1.90
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry (2005) 1.52
The COMT val158met polymorphism and brain morphometry in healthy young adults. Neurosci Lett (2006) 1.25
Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res (2004) 1.22
Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Can J Psychiatry (2004) 1.15
Disability in people clinically at high risk of psychosis. Br J Psychiatry (2010) 1.10
Attitudes of patients toward the first psychotic episode and the start of treatment. Schizophr Bull (2002) 1.09
Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr Res (2012) 1.04
Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res (2011) 1.02
White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia. Schizophr Res (2011) 0.94
Antisaccade task performance in patients at ultra high risk for developing psychosis. Schizophr Res (2007) 0.94
Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry (2003) 0.93
Obsessive-compulsive symptoms and positive, negative, and depressive symptoms in patients with recent-onset schizophrenic disorders. Can J Psychiatry (2005) 0.87
Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients. Psychopharmacol Bull (2006) 0.87
Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology. J Psychopharmacol (2011) 0.85
Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone. Psychoneuroendocrinology (2009) 0.85
Proton magnetic resonance spectroscopy in 22q11 deletion syndrome. PLoS One (2011) 0.85
Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. Neuropsychopharmacology (2007) 0.84
Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up. Soc Psychiatry Psychiatr Epidemiol (2012) 0.84
Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis. Psychiatry Res (2013) 0.83
Subjective experiences during dopamine depletion. Am J Psychiatry (2005) 0.83
Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study. J Psychopharmacol (2010) 0.83
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Can J Psychiatry (2008) 0.82
Associations between the Five-Factor Model personality traits and psychotic experiences in patients with psychotic disorders, their siblings and controls. Psychiatry Res (2013) 0.80
Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry (2004) 0.80
Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study. Eur Neuropsychopharmacol (2013) 0.79
The trainee project: family-aided vocational rehabilitation of young people with schizophrenia. Psychiatr Rehabil J (2002) 0.78
Subjective effects of cannabis before the first psychotic episode. Aust N Z J Psychiatry (2009) 0.77
Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results. Psychiatry Res (2007) 0.77
Perceived negative attitude of others as an early sign of psychosis. Eur Psychiatry (2009) 0.77
Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets. Psychopharmacology (Berl) (2004) 0.77
Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): a self-report screen for ultrahigh risk and acute psychosis. Psychol Assess (2010) 0.77
Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. J Clin Psychopharmacol (2008) 0.76
Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia. Psychopharmacology (Berl) (2005) 0.76
Visual scan paths in young patients with schizophrenia, healthy siblings and controls. Schizophr Res (2006) 0.76
Field testing attenuated psychosis syndrome criteria. Am J Psychiatry (2011) 0.75
Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics. Am J Psychiatry (2005) 0.75
Social disability at admission for a first psychosis does not predict clinical outcome at 5-year follow-up. J Nerv Ment Dis (2011) 0.75
Blinding in clozapine trials: a problem and a potential solution. Int J Methods Psychiatr Res (2009) 0.75